Representative Warren Davidson (Republican-Ohio) recently sold shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC). In a filing disclosed on March 25th, the Representative disclosed that they had sold between $1,001 and $15,000 in GE HealthCare Technologies stock on March 23rd.
GE HealthCare Technologies Stock Performance
Shares of NASDAQ GEHC opened at $69.23 on Friday. The company has a 50-day simple moving average of $77.91 and a 200-day simple moving average of $78.26. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The company has a market cap of $31.59 billion, a PE ratio of 15.18, a price-to-earnings-growth ratio of 1.57 and a beta of 1.03. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $89.77.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. During the same period in the prior year, the firm posted $1.45 earnings per share. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
Analysts Set New Price Targets
Several analysts recently issued reports on the company. Citigroup lowered their price target on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a report on Wednesday, March 11th. Stifel Nicolaus upped their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Jefferies Financial Group raised their target price on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a report on Thursday, December 11th. Finally, UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and boosted their price target for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Hold” and an average target price of $92.17.
View Our Latest Stock Analysis on GE HealthCare Technologies
Institutional Investors Weigh In On GE HealthCare Technologies
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Laurel Wealth Advisors LLC acquired a new position in GE HealthCare Technologies in the fourth quarter worth $26,000. Optima Capital LLC bought a new position in shares of GE HealthCare Technologies in the 4th quarter worth about $27,000. Godfrey Financial Associates Inc. bought a new position in shares of GE HealthCare Technologies in the 4th quarter worth about $27,000. Montag A & Associates Inc. boosted its holdings in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.
About Representative Davidson
Warren Davidson (Republican Party) is a member of the U.S. House, representing Ohio’s 8th Congressional District. He assumed office on June 9, 2016. His current term ends on January 3, 2027.
Davidson (Republican Party) ran for re-election to the U.S. House to represent Ohio’s 8th Congressional District. He won in the general election on November 5, 2024.
Davidson received his undergraduate degree from West Point and his MBA from Notre Dame. He served in the Old Guard, 75th Ranger Regiment and 101st Airborne Division of the U.S. Army.
About GE HealthCare Technologies
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Further Reading
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
